Cash flows from operations (before changes in non-cash working capital items) for the third quarter of 2007 were US$11.2 million and were US$7.8 million for the same period last year. In July 2007, Atrium modified its existing revolving credit facility by increasing the authorized amount to US$350 million with the possibility to increase it up to US$425 million under certain conditions. This increases the financing flexibility of the Company and will permit it to continue its acquisition strategy in each of his Divisions.
A Solid Management Team
In addition, during the last quarter, the Company announced the appointment of Dr. Serge Yelle as Executive Vice-President, Health & Nutrition Division. In addition to supervising the operations of certain business units, Dr. Yelle has played a key role over the past few years in the integration of companies acquired by Atrium, including Douglas Laboratories and Mucos.
"Atrium today has reached the stage of a mature corporation and can also count on a highly-skilled and experienced management team demonstrating longstanding expertise and vast know-how. This is in addition to the talent and commitment of our 600 or so employees based in various regions of the world. All these assets have enabled Atrium to become a true world leader in its field in just a few years and they provide us with a solid foundation to pursue our growth and development strategy aggressively", Mr. Fitzgibbon said.
Health & Nutrition Division
Revenues from the Health & Nutrition Division were US$50.9 million for
the third quarter ended September 30, 2007, representing an increase of
80.0% over revenues of US$28.3 million for the same period last year. This
increase can primarily be explained by the acquisition of Mucos in July
2007. EBITDA was US$15.3 million for the third quarter o
|SOURCE Atrium Innovations Inc.|
Copyright©2007 PR Newswire.
All rights reserved